New Drug Targets Brain Glial Cells to Reverse PTSD Symptoms
A new study identifies excess GABA produced by astrocytes via MAOB enzyme as a key factor in PTSD, and demonstrates that the MAOB inhibitor KDS2010 can reverse PTSD-like symptoms in mice, opening new avenues for glial-targeted therapies in humans.